Michael Petusky
Stock Analyst at Barrington
(3.75)
# 2,030
Out of 5,058 analysts
610
Total ratings
45.2%
Success rate
3.7%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LMAT LeMaitre Vascular | Reiterated: Buy | $95 | $82.62 | +14.98% | 59 | Oct 13, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $114 | $87.16 | +30.79% | 84 | Oct 12, 2026 | |
| HAE Haemonetics | Reiterated: Buy | $118 → $140 | $121.11 | +15.60% | 69 | Oct 9, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $104 | $85.56 | +21.55% | 48 | Oct 9, 2026 | |
| OPCH Option Care Health | Downgraded: Hold | n/a | $31.12 | - | 59 | Oct 7, 2026 | |
| ANIK Anika Therapeutics | Reiterated: Buy | $21 → $23 | $20.25 | +13.58% | 51 | Oct 1, 2026 | |
| LFCR Lifecore Biomedical | Downgraded: Hold | n/a | $6.42 | - | 41 | Oct 1, 2026 | |
| VMD Viemed Healthcare | Reiterated: Buy | $14 | $9.69 | +44.48% | 2 | Oct 1, 2026 | |
| USPH U.S. Physical Therapy | Reiterated: Buy | $90 → $98 | $84.91 | +15.42% | 60 | Aug 10, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Buy | $17 → $15 | $8.44 | +77.73% | 57 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $18 | $13.50 | +33.33% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $14 | $9.25 | +51.35% | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.37 | - | 54 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 | $3.05 | -50.82% | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $39.95 | n/a | 1 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $30 | $21.82 | n/a | 1 | Apr 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6.5 | $1.02 | n/a | 1 | Aug 14, 2013 |
LeMaitre Vascular
Oct 13, 2026
Reiterated: Buy
Price Target: $95
Current: $82.62
Upside: +14.98%
Merit Medical Systems
Oct 12, 2026
Reiterated: Buy
Price Target: $114
Current: $87.16
Upside: +30.79%
Haemonetics
Oct 9, 2026
Reiterated: Buy
Price Target: $118 → $140
Current: $121.11
Upside: +15.60%
Henry Schein
Oct 9, 2026
Reiterated: Buy
Price Target: $104
Current: $85.56
Upside: +21.55%
Option Care Health
Oct 7, 2026
Downgraded: Hold
Price Target: n/a
Current: $31.12
Upside: -
Anika Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $21 → $23
Current: $20.25
Upside: +13.58%
Lifecore Biomedical
Oct 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $6.42
Upside: -
Viemed Healthcare
Oct 1, 2026
Reiterated: Buy
Price Target: $14
Current: $9.69
Upside: +44.48%
U.S. Physical Therapy
Aug 10, 2026
Reiterated: Buy
Price Target: $90 → $98
Current: $84.91
Upside: +15.42%
DENTSPLY SIRONA
Aug 10, 2026
Reiterated: Buy
Price Target: $17 → $15
Current: $8.44
Upside: +77.73%
Aug 6, 2026
Reiterated: Buy
Price Target: $14 → $18
Current: $13.50
Upside: +33.33%
Aug 6, 2026
Reiterated: Buy
Price Target: $17 → $14
Current: $9.25
Upside: +51.35%
Jul 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.37
Upside: -
Jan 6, 2026
Reiterated: Buy
Price Target: $1.5
Current: $3.05
Upside: -50.82%
Jun 9, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $39.95
Upside: n/a
Dec 18, 2017
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 25, 2016
Upgraded: Buy
Price Target: $30
Current: $21.82
Upside: n/a
Aug 14, 2013
Rated: Buy
Price Target: $6.5
Current: $1.02
Upside: n/a